Bingyi Chen, PhD
New York, NY
United States
Memorial Sloan Kettering Cancer Center
I am a Research Scholar in the laboratory of Dr. Omar Abdel-Wahab at Memorial Sloan Kettering Cancer Center. I obtained my Bachelor’s degree at East China University of Science and Technology and completed my PhD training at the Shanghai Institute of Nutrition and Health in the University of Chinese Academy of Sciences under the mentorship of Dr. Lan Wang. During my graduate studies, I identified an important role of the histone methyltransferase SETD2 in the transformation of patients with myelodysplastic syndromes (MDS) to acute myeloid leukemia (AML). As an LLS Special Fellow, I will focus on developing novel CAR-T cell therapy targeting cell surface expression of the RNA helicase U5 snRNP200. Moreover, I will explore the mechanistic basis for cell surface localization of U5 snRNP200 on AML cells. I hope that my work has immediate therapeutic potential for the future treatment of AML while shedding important novel insights into the pathobiology of AML.